V. Jendrossek et al., AN IN-FRAME TRIPLET DELETION WITHIN THE GP91-PHOX GENE IN AN ADULT X-LINKED CHRONIC GRANULOMATOUS-DISEASE PATIENT WITH RESIDUAL NADPH-OXIDASE ACTIVITY, European journal of haematology, 58(2), 1997, pp. 78-85
In an adult patient suffering from X-linked chronic granulomatous dise
ase (X-CGD) with residual activity of the NADPH-oxidase we found an un
usual biochemical constellation with a defective gp91-phox gene. As sh
own by Western blot using a specific antibody the gp91-phox protein wa
s normal in PMN. However, NADPH-oxidase activity was reduced and no he
me spectrum was detectable. By Southern blot and RFLP analysis of geno
mic DNA a larger defect within the gp91-phox gene was excluded. Sequen
cing of the gp91-phox cDNA revealed an in-frame deletion of a TTC trip
let in exon VI of the gp91-phox gene. This mutation indicates the loss
of one amino acid (phenylalanine 215 or 216) in the gp91-phox protein
. Sequencing of genomic DNA from the heterozygous daughter of the prop
ositus confirmed this mutation. The absence of a functional cytochrome
b(588)-spectrum in granulocytes of the patient suggests an involvemen
t of the phenylalanine 216 area in heme binding by gp91-phox. This is
the first mutation described in a X-CGD patient with absence of a func
tional cytochrome b(558)-spectrum but with detectable gp91-phox protei
n and residual NADPH-oxidase activity.